Amarin Corp Plc (AMRN)

[Mr Stockboy]

IMO the buy-back will cut into share supply and set the stage for a faster-rising share demand as if I remember Amarin has hefty percentage of long-investors (private and institutional). Furthermore, Amarin is selling E-EPA (C22H34O2), not EPA (C20H30O2), thanks for ORBAPU for clarification, just dig into patent 11690820 "Claim 5. The pharmaceutical composition of claim 1, wherein the eicosapentaenoic acid is ethyl eicosapentaenoate"... E-EPA is a novel creation in the lab; EPA is found in fish. I regret not one legal-beagle to date has yet to grasp what Amarin's lawyers were supposed to be defending in court: E-EPA, not EPA. There was definitely no prior "art" regarding E-EPA which meant the opposition's citing of prior art was EPA, not E-EPA created in the lab, not found in fish. Just look at the chemical chain; they are not the same. "Your honor Judge Du, we are here to defend E-EPA, not EPA, as there is no prior art for E-EPA. Our opponents Judge are talking about the wrong molecule. We rest our case."